This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lauenborg, J. Articles by Damm, P. Search for Related Content PubMed PubMed Citation Articles by Lauenborg, J. Articles by Damm, P. Related Collections Diabetes and Insulin Female Endocrinology Metabolism

The Prevalence of the Metabolic Syndrome in a Danish Population of Women with Previous Gestational Diabetes Mellitus Is Three-Fold Higher than in the General Population

Departments of Obstetrics (J.L., P.H., P.D.) and Endocrinology (E.M.), Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark; Steno Diabetes Center (T.H., C.G., K.B.-J., O.P.), 2820 Gentofte, Denmark; and Research Center for Prevention and Health (T.J.), Glostrup University Hospital, 2600 Glostrup, Denmark

Address all correspondence and requests for reprints to: Jeannet Lauenborg, M.D., Department of Obstetrics, 4031, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. E-mail: jeannet{at}lauenb.org.

Context: Diabetes and obesity, components of the metabolic syndrome, are common characteristics of women with prior gestational diabetes mellitus (GDM). Due to increasing incidence of diabetes and obesity, the metabolic syndrome might comprise a major health problem among these women.

Objective: The objective was to estimate the prevalence of the metabolic syndrome by three different criteria [World Health Organization 1999 (WHO), The National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001, and European Group for the Study of Insulin Resistance 2002] among women with previous GDM.

Design: We conducted a follow-up study of a Danish cohort of women admitted in 1978–1996 to the Diabetes and Pregnancy Center, Rigshospitalet, Copenhagen University Hospital, with diet-treated GDM. The follow-up took place in 2000–2002 at median 9.8 yr (interquartile range 6.4–17.2) after pregnancy. Results were compared with a control group of 1000 age-matched women from a population-based sample (Inter99).

Participants: Four hundred eighty-one women at median age 43 yr (interquartile range 38–48) participated.

Main Outcome Measures: The main outcome measures were body mass index (BMI), glucose tolerance, blood pressure, lipid profile, and insulin resistance.

Results: Independent of the criteria, the prevalence of the metabolic syndrome was three times higher in the prior GDM group, compared with the control group (e.g. WHO: 38.4 vs. 13.4%, P < 0.0005). Age- and BMI-adjusted odds ratio for having the WHO-defined metabolic syndrome was 3.4 (95% confidence interval 2.5–4.8) for the prior GDM group vs. the control group. Obese women (BMI > 30 kg/m²) with previous GDM had a more than 7-fold increased prevalence of the metabolic syndrome (WHO), compared with normal-weight prior GDM women (BMI < 25 kg/m²). In glucose-tolerant women, the prevalence was doubled in the prior GDM group, compared with control group.

Conclusion: The prevalence of the metabolic syndrome was three times as high in women with prior diet-treated GDM, compared with age-matched control subjects.

This article has been cited by other articles:

				R. Retnakaran, Y. Qi, P. W. Connelly, M. Sermer, B. Zinman, and A. J. G. Hanley Glucose Intolerance in Pregnancy and Postpartum Risk of Metabolic Syndrome in Young Women J. Clin. Endocrinol. Metab., February 1, 2010; 95(2): 670 - 677. [Abstract] [Full Text] [PDF]

				J. Pirkola, A. Pouta, A. Bloigu, S. Miettola, A.-L. Hartikainen, M.-R. Jarvelin, and M. Vaarasmaki Prepregnancy Overweight and Gestational Diabetes as Determinants of Subsequent Diabetes and Hypertension after 20-Year Follow-Up J. Clin. Endocrinol. Metab., February 1, 2010; 95(2): 772 - 778. [Abstract] [Full Text] [PDF]

				R. Retnakaran and B. R. Shah Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study Can. Med. Assoc. J., September 15, 2009; 181(6-7): 371 - 376. [Abstract] [Full Text] [PDF]

				M.-A. Cornier, D. Dabelea, T. L. Hernandez, R. C. Lindstrom, A. J. Steig, N. R. Stob, R. E. Van Pelt, H. Wang, and R. H. Eckel The Metabolic Syndrome Endocr. Rev., December 1, 2008; 29(7): 777 - 822. [Abstract] [Full Text] [PDF]

				M. M. Hedderson and A. Ferrara High Blood Pressure Before and During Early Pregnancy Is Associated With an Increased Risk of Gestational Diabetes Mellitus Diabetes Care, December 1, 2008; 31(12): 2362 - 2367. [Abstract] [Full Text] [PDF]

				B. R. Shah, R. Retnakaran, and G. L. Booth Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus Diabetes Care, August 1, 2008; 31(8): 1668 - 1669. [Abstract] [Full Text] [PDF]

				A. H. Xiang, M. Kawakubo, T. A. Buchanan, and S. L. Kjos A Longitudinal Study of Lipids and Blood Pressure in Relation to Method of Contraception in Latino Women With Prior Gestational Diabetes Mellitus Diabetes Care, August 1, 2007; 30(8): 1952 - 1958. [Abstract] [Full Text] [PDF]

				J. L. Kitzmiller, L. Dang-Kilduff, and M. M. Taslimi Gestational Diabetes After Delivery: Short-term management and long-term risks Diabetes Care, July 1, 2007; 30(Supplement_2): S225 - S235. [Full Text] [PDF]

				P. Damm, E. R. Mathiesen, K. R. Petersen, and S. Kjos Contraception After Gestational Diabetes Diabetes Care, July 1, 2007; 30(Supplement_2): S236 - S241. [Full Text] [PDF]